<?xml version='1.0' encoding='utf-8'?>
<document id="26800424"><sentence text="Effects of Silymarin, Glycyrrhizin, and Oxymatrine on the Pharmacokinetics of Ribavirin and Its Major Metabolite in Rats."><entity charOffset="11-20" id="DDI-PubMed.26800424.s1.e0" text="Silymarin" /><entity charOffset="22-34" id="DDI-PubMed.26800424.s1.e1" text="Glycyrrhizin" /><entity charOffset="40-50" id="DDI-PubMed.26800424.s1.e2" text="Oxymatrine" /><entity charOffset="78-87" id="DDI-PubMed.26800424.s1.e3" text="Ribavirin" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e0" e2="DDI-PubMed.26800424.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e0" e2="DDI-PubMed.26800424.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e0" e2="DDI-PubMed.26800424.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e0" e2="DDI-PubMed.26800424.s1.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e1" e2="DDI-PubMed.26800424.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e1" e2="DDI-PubMed.26800424.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e1" e2="DDI-PubMed.26800424.s1.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e2" e2="DDI-PubMed.26800424.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s1.e2" e2="DDI-PubMed.26800424.s1.e3" /></sentence><sentence text="The herb-derived compounds silymarin, glycyrrhizin, and oxymatrine are widely used to treat chronic hepatitis C virus infections in China"><entity charOffset="27-36" id="DDI-PubMed.26800424.s2.e0" text="silymarin" /><entity charOffset="38-50" id="DDI-PubMed.26800424.s2.e1" text="glycyrrhizin" /><entity charOffset="56-66" id="DDI-PubMed.26800424.s2.e2" text="oxymatrine" /><pair ddi="false" e1="DDI-PubMed.26800424.s2.e0" e2="DDI-PubMed.26800424.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s2.e0" e2="DDI-PubMed.26800424.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s2.e0" e2="DDI-PubMed.26800424.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s2.e1" e2="DDI-PubMed.26800424.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s2.e1" e2="DDI-PubMed.26800424.s2.e2" /></sentence><sentence text=" They are often prescribed in combination with ribavirin, which has a narrow therapeutic index"><entity charOffset="47-56" id="DDI-PubMed.26800424.s3.e0" text="ribavirin" /></sentence><sentence text=" We investigated the influence of these compounds on ribavirin pharmacokinetics following concurrent administration at the human dose in rats"><entity charOffset="53-62" id="DDI-PubMed.26800424.s4.e0" text="ribavirin" /></sentence><sentence text=" Pharmacokinetic parameters were determined in rats following oral (p" /><sentence text="o" /><sentence text=") administration of ribavirin (30 mg/kg) with or without silymarin (40 mg/kg, p"><entity charOffset="20-29" id="DDI-PubMed.26800424.s7.e0" text="ribavirin" /><entity charOffset="57-66" id="DDI-PubMed.26800424.s7.e1" text="silymarin" /><pair ddi="false" e1="DDI-PubMed.26800424.s7.e0" e2="DDI-PubMed.26800424.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s7.e0" e2="DDI-PubMed.26800424.s7.e1" /></sentence><sentence text="o" /><sentence text="), glycyrrhizin (15 mg/kg, intraperitoneal [i"><entity charOffset="3-15" id="DDI-PubMed.26800424.s9.e0" text="glycyrrhizin" /></sentence><sentence text="p" /><sentence text="]), or oxymatrine (60 mg/kg, p"><entity charOffset="7-17" id="DDI-PubMed.26800424.s11.e0" text="oxymatrine" /></sentence><sentence text="o" /><sentence text=")" /><sentence text=" Compared with the animals in ribavirin group, silymarin significantly decreased the area under the plasma concentration-time curve (AUC0-t ) and the peak plasma concentration (Cmax ) of ribavirin and ribavirin base by 31"><entity charOffset="30-39" id="DDI-PubMed.26800424.s14.e0" text="ribavirin" /><entity charOffset="47-56" id="DDI-PubMed.26800424.s14.e1" text="silymarin" /><entity charOffset="187-196" id="DDI-PubMed.26800424.s14.e2" text="ribavirin" /><entity charOffset="201-210" id="DDI-PubMed.26800424.s14.e3" text="ribavirin" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e0" e2="DDI-PubMed.26800424.s14.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e0" e2="DDI-PubMed.26800424.s14.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e0" e2="DDI-PubMed.26800424.s14.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e0" e2="DDI-PubMed.26800424.s14.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e1" e2="DDI-PubMed.26800424.s14.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e1" e2="DDI-PubMed.26800424.s14.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e1" e2="DDI-PubMed.26800424.s14.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e2" e2="DDI-PubMed.26800424.s14.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s14.e2" e2="DDI-PubMed.26800424.s14.e3" /></sentence><sentence text="2-44" /><sentence text="5% and 48" /><sentence text="9-50" /><sentence text="0%, respectively" /><sentence text=" Glycyrrhizin significantly decreased the Cmax and AUC0-t of both ribavirin and its metabolite by 35"><entity charOffset="1-13" id="DDI-PubMed.26800424.s19.e0" text="Glycyrrhizin" /><entity charOffset="66-75" id="DDI-PubMed.26800424.s19.e1" text="ribavirin" /><pair ddi="false" e1="DDI-PubMed.26800424.s19.e0" e2="DDI-PubMed.26800424.s19.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s19.e0" e2="DDI-PubMed.26800424.s19.e1" /></sentence><sentence text="3-37" /><sentence text="6% and 38" /><sentence text="6-39" /><sentence text="8%, respectively" /><sentence text=" However, silymarin or glycyrrhizin did not change the ribavirin metabolite/parent ratios of the AUC and Cmax "><entity charOffset="10-19" id="DDI-PubMed.26800424.s24.e0" text="silymarin" /><entity charOffset="23-35" id="DDI-PubMed.26800424.s24.e1" text="glycyrrhizin" /><entity charOffset="55-64" id="DDI-PubMed.26800424.s24.e2" text="ribavirin" /><pair ddi="false" e1="DDI-PubMed.26800424.s24.e0" e2="DDI-PubMed.26800424.s24.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s24.e0" e2="DDI-PubMed.26800424.s24.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s24.e0" e2="DDI-PubMed.26800424.s24.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s24.e1" e2="DDI-PubMed.26800424.s24.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s24.e1" e2="DDI-PubMed.26800424.s24.e2" /></sentence><sentence text=" Oxymatrine did not induce significant changes in ribavirin concentration, but it significantly decreased the Cmax (26"><entity charOffset="1-11" id="DDI-PubMed.26800424.s25.e0" text="Oxymatrine" /><entity charOffset="50-59" id="DDI-PubMed.26800424.s25.e1" text="ribavirin" /><pair ddi="false" e1="DDI-PubMed.26800424.s25.e0" e2="DDI-PubMed.26800424.s25.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s25.e0" e2="DDI-PubMed.26800424.s25.e1" /></sentence><sentence text="6%) and AUC (21" /><sentence text="8%) of the metabolite" /><sentence text=" This study indicates that the therapeutic efficacy of ribavirin may be compromised by the concurrent administration of herbal medicines/dietary supplements containing silymarin, glycyrrhizin, or oxymatrine"><entity charOffset="55-64" id="DDI-PubMed.26800424.s28.e0" text="ribavirin" /><entity charOffset="168-177" id="DDI-PubMed.26800424.s28.e1" text="silymarin" /><entity charOffset="179-191" id="DDI-PubMed.26800424.s28.e2" text="glycyrrhizin" /><entity charOffset="196-206" id="DDI-PubMed.26800424.s28.e3" text="oxymatrine" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e0" e2="DDI-PubMed.26800424.s28.e0" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e0" e2="DDI-PubMed.26800424.s28.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e0" e2="DDI-PubMed.26800424.s28.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e0" e2="DDI-PubMed.26800424.s28.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e1" e2="DDI-PubMed.26800424.s28.e1" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e1" e2="DDI-PubMed.26800424.s28.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e1" e2="DDI-PubMed.26800424.s28.e3" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e2" e2="DDI-PubMed.26800424.s28.e2" /><pair ddi="false" e1="DDI-PubMed.26800424.s28.e2" e2="DDI-PubMed.26800424.s28.e3" /></sentence><sentence text="" /></document>